Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 40.62M P/E - EPS this Y 62.10% Ern Qtrly Grth -
Income -59.33M Forward P/E -2.12 EPS next Y 48.00% 50D Avg Chg 27.00%
Sales 90.3M PEG 0.00 EPS past 5Y - 200D Avg Chg 60.00%
Dividend N/A Price/Book N/A EPS next 5Y 20.00% 52W High Chg -78.00%
Recommedations 1.00 Quick Ratio 0.29 Shares Outstanding 11.96M 52W Low Chg 190.00%
Insider Own 9.61% ROA -20.57% Shares Float 11.05M Beta 2.03
Inst Own 17.04% ROE - Shares Shorted/Prior 1.31M/1.36M Price 3.63
Gross Margin 42.11% Profit Margin -65.48% Avg. Volume 1,244,437 Target Price 2.00
Oper. Margin -48.08% Earnings Date Mar 28 Volume 215,767 Change -5.96%
About Sientra, Inc.

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Bennett Oliver Christian GC & Chief Complianc.. GC & Chief Compliance Officer Jul 12 Sell 7.33 6,864 50,313 73,141 07/12/21